Arcus Biosciences Inc (RCUS)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 108,000 | -8,000 | 2,000 | 306,753 | 32,064 |
| Revenue | US$ in thousands | 258,000 | 117,000 | 112,000 | 382,882 | 77,517 |
| Gross profit margin | 41.86% | -6.84% | 1.79% | 80.12% | 41.36% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $108,000K ÷ $258,000K
= 41.86%
Based on the data provided, the gross profit margin of Arcus Biosciences Inc has demonstrated significant fluctuations over the years.
In December 31, 2020, the gross profit margin stood at 41.36%, indicating that the company was able to generate a relatively healthy profit after accounting for the cost of goods sold.
By December 31, 2021, there was a substantial increase in the gross profit margin to 80.12%, reflecting an improvement in the company's efficiency in managing production costs and increasing revenue.
However, in December 31, 2022, there was a notable decline in the gross profit margin to 1.79%, signaling potential challenges in maintaining profitability and controlling costs.
The situation worsened in December 31, 2023, with a negative gross profit margin of -6.84%, which suggests that the company's costs exceeded its revenue, resulting in a loss at the gross profit level.
By December 31, 2024, there was a partial recovery in the gross profit margin to 41.86%, indicating some improvement in the company's profitability position.
Overall, the fluctuating trend in Arcus Biosciences Inc's gross profit margin highlights the importance of closely monitoring cost management and revenue generation strategies to sustain profitability and financial health.
Peer comparison
Dec 31, 2024